Alora Pharmaceuticals was hit with a patent infringement lawsuit on Oct. 13 in Georgia Northern District Court over its planned generic version of an isosulfan blue injection product. The action, ...
ROCKFORD, Ill., March 18, 2019 /PRNewswire/ -- Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL tothe ...
POTTERS BAR, England and PITTSBURGH, Feb. 27, 2015 /PRNewswire/ -- Mylan N.V. and Mylan Inc. (Nasdaq: MYL) today announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ...
San Antonio’s DPT Laboratories, which manufactures topical medications, will soon be answering to a new parent company — global pharmaceutical company Mylan — if a $1 billion deal closes this fall as ...
Based on the governing Federal Circuit case law, where the patent claim at issue is directed to a specific component (such as a specific enantiomer) of a prior art mixture (such as a racemic drug ...
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until December 12, 2016 to ...
For the details of Integrated Investment Consultants, LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Integrated+Investment ...
Mylan Institutional LLC Initiates Voluntary Nationwide Recall of Levoleucovorin Injection Due to the
Mylan Institutional LLC is conducting a voluntary nationwide recall of two lots (see table below) of Levoleucovorin Injection, 250 mg/25 mL to the consumer/user level. The lots were manufactured by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback